RI039, RNase Inhibitor, recombinant Human Placenta Ribonuclease Inhibitor, 40U/μl
RNase Inhibitor
1μg of Lambda DNA is incubated with 200 units of Ribonuclease Inhibitor for 16 hours at 37°C.
Following incubation, Lambda DNA is visualized as intact on an ethidium bromide-stained agarose gel to verify the absence of visible Endonuclease.
1μg of Type I supercoiled pBR322 is incubated with 200 units of Ribonuclease Inhibitor for 4 hours at 37°C.
Following incubation, the supercoiled DNA is visualized on an ethidium bromide-stained agarose gel to verify the absence of visible nicking or cutting.
1μg of Lambda DNA/HindIII Markers is incubated with 200 units of Ribonuclease Inhibitor for 16 hours at 37°C.
Following incubation, Lambda DNA/HindIII Markers is separated by 1% agarose gel and stained with ethidium bromide. Markers remain as intact bands without smearing.
To test for the presence of RNase activity, 1ug of RNA is incubated with 200 units of Ribonuclease Inhibitor for 4 hours at 37°C.
Following incubation, the RNA is visualized as intact band on an ethidium bromide-stained agarose gel to verify the absence of visible RNase.
To test for the presence of latent RNase activity, 200units of Ribonuclease Inhibitor is heat-denatured at 70°C for 15minutes and incubated with 1ug of RNA for 4 hours at 37°C.
Following incubation, the RNA is visualized as intact band on an ethidium bromide-stained agarose gel to verify the absence of visible RNase.
recombinant Human Placenta Ribonuclease Inhibitor, 40U/μl
recombinant Murine Ribonuclease Inhibitor, 40U/μl
recombinant Murine Ribonuclease Inhibitor, GMP Grade, for medical mRNA synthesis and other biopharmaceutical production. Size: 40U/μl*75ul/vial
Designed with Mobirise
Web Design Software